AnalyzeDirect

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. The Lancet Neurology. Publication Date March 18, 2019 How Analyze was Used “Areas of the haematoma and perihaematomal oedema were automatically delineated with imaging analysis software (Analyze 11.0 Visualization and Analysis Software for Medical Imaging;…